1143 POSTER Oral palonosetron (PALO) is as effective as intravenous (IV) PALO: a phase 3 dose ranging trial in patients (pts) receiving moderately emetogenic chemotherapy (MEC)

✍ Scribed by S. Grunberg; D. Voisin; M. Zufferli; G. Piraccini

• Book ID: 118625504
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 61 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70662-6